Olfactory receptor Olfr544 responding to azelaic acid regulates glucagon secretion in α-cells of mouse pancreatic islets

N Kang, YY Bahk, N Lee, YG Jae, YH Cho… - Biochemical and …, 2015 - Elsevier
N Kang, YY Bahk, N Lee, YG Jae, YH Cho, CR Ku, Y Byun, EJ Lee, MS Kim, JH Koo
Biochemical and biophysical research communications, 2015Elsevier
Olfactory receptors (ORs) are extensively expressed in olfactory as well as non-olfactory
tissues. Although many OR transcripts are expressed in non-olfactory tissues, only a few
studies demonstrate the functional role of ORs. Here, we verified that mouse pancreatic α-
cells express potential OR-mediated downstream effectors. Moreover, high levels of mRNA
for the olfactory receptors Olfr543, Olfr544, Olfr545, and Olfr1349 were expressed in α-cells
as assessed using RNA-sequencing, microarray, and quantitative real-time RT-PCR …
Abstract
Olfactory receptors (ORs) are extensively expressed in olfactory as well as non-olfactory tissues. Although many OR transcripts are expressed in non-olfactory tissues, only a few studies demonstrate the functional role of ORs. Here, we verified that mouse pancreatic α-cells express potential OR-mediated downstream effectors. Moreover, high levels of mRNA for the olfactory receptors Olfr543, Olfr544, Olfr545, and Olfr1349 were expressed in α-cells as assessed using RNA-sequencing, microarray, and quantitative real-time RT-PCR analyses. Treatment with dicarboxylic acids (azelaic acid and sebacic acid) increased intracellular Ca2+ mobilization in pancreatic α-cells. The azelaic acid-induced Ca2+ response as well as glucagon secretion was concentration- and time-dependent manner. Olfr544 was expressed in α-cells, and the EC50 value of azelaic acid to Olfr544 was 19.97 μM, whereas Olfr545 did not respond to azelaic acid. Our findings demonstrate that Olfr544 responds to azelaic acid to regulate glucagon secretion through Ca2+ mobilization in α-cells of the mouse pancreatic islets, suggesting that Olfr544 may be an important therapeutic target for metabolic diseases.
Elsevier